AstraZeneca Pharma India Limited (NSE:ASTRAZEN)
India flag India · Delayed Price · Currency is INR
6,570.50
+56.00 (0.86%)
Nov 11, 2026, 1:13 PM IST

AstraZeneca Pharma India Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
164,205193,986215,159133,01081,18363,886
Market Cap Growth
-27.65%-9.84%61.76%63.84%27.07%-15.11%
Enterprise Value
159,415190,335210,362127,86176,55260,484
Last Close Price
6514.507730.968540.185268.883202.792505.77

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
92.43103.45185.9082.3581.76103.71
PS Ratio
6.328.5312.5410.278.097.93
PB Ratio
18.7222.2327.9318.6813.7912.49
P/TBV Ratio
18.7222.2327.9518.7413.7912.49
P/FCF Ratio
61.82-338.25777.38163.1270.07
P/OCF Ratio
58.14-329.19477.25139.2763.38

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
EV/Sales Ratio
6.148.3612.269.877.637.51
EV/EBITDA Ratio
63.9275.9384.6769.8147.4573.16
EV/EBIT Ratio
69.2981.4397.9374.5851.4387.20
EV/FCF Ratio
60.02-330.71747.29153.8166.33

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
0.110.130.050.010.010.02
Debt / EBITDA Ratio
0.390.420.140.020.040.10
Debt / FCF Ratio
0.36-0.560.270.140.10
Net Debt / Equity Ratio
-0.55-0.39-0.65-0.70-0.84-0.86
Net Debt / EBITDA Ratio
-1.95-1.34-2.01-2.73-3.06-5.32
Net Debt / FCF Ratio
-1.8020.18-7.87-29.28-9.91-4.82
Asset Turnover
1.371.301.321.261.090.99
Inventory Turnover
1.861.762.502.872.222.11
Quick Ratio
0.720.681.051.891.611.64
Current Ratio
1.631.771.912.612.182.12
Return on Equity (ROE)
21.19%22.82%15.62%24.84%18.05%12.73%
Return on Assets (ROA)
7.80%8.33%10.34%10.39%10.11%5.32%
Return on Invested Capital (ROIC)
36.98%43.14%66.13%82.29%131.87%54.86%
Return on Capital Employed (ROCE)
23.70%23.20%26.40%23.80%24.80%13.20%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
1.08%0.97%0.54%1.21%1.22%0.96%
FCF Yield
1.62%-0.09%0.30%0.13%0.61%1.43%
Dividend Yield
0.55%0.46%0.37%0.45%0.49%0.39%
Payout Ratio
50.64%42.66%51.84%24.77%20.14%8.12%
Total Shareholder Return
0.51%0.46%0.37%0.45%0.49%0.39%